TEK and colorectal carcinoma: The lack of effect in these Tie2‐IFNα mice—where, like in the other groups, tumor cells have the potential to respond to IFNα—also argues against the possibility of a direct anti‐tumor activity of IFNα on CRC cells as principal anti‐tumor mechanism.